What are the opening hours?

Monday 9am - 5pm Tuesday 9am - 5pm Wednesday 9am - 5pm Thursday 9am - 5pm Friday 9am - 5pm

Cellular Engineering Technologies, Inc.

Name: Cellular Engineering Technologies, Inc.
Address: 2500 Crosspark Road, Coralville, IA, 52241, US
Telephone: (319) 665-3000
Price range: £

Nearby engineering companies

SantosHuman Inc.
Crosspark Road

VJ Engineering
Holiday Road

Tucker Burnes Audio Engineering
North Liberty 52317

Shoemaker & Haaland Professional Engineers
Holiday Road

PRVN Consultants, Inc.
Pacha Pkwy, North Liberty

Hart-Frederick Consultants PC
State Street, Tiffin

Architectural Metal Folding Inc
Stoner Court, North Liberty

Grace.Lighting
Willow Creek Drive, Iowa City

Comments

The USPTO Issues a Patent to Cellular Engineering Technologies for Producing Safer Induced Pluripotent Stem Cells - https://bioinformant.com/cellular-engineering-technologies/

Cellular Engineering Technologies, Inc. (CET), Inc., an Iowa biotechnology company specializing in cell manufacturing and contract research services, announced that it has received a patent from the United States Patent and Trademark Office for its virus-free and oncogene-free induced pluripotent stem cell (iPSC) technology.

The iPSC technology which was previously published in Future Science Open Access and Regenerative Medicine was developed in collaboration with the John Paul II Medical Research Institute (JP2MRI), a non-profit organization.

More recently, the National Institutes of Health awarded CET a SBIR grant to commercialize the technology to provide reproducible iPSC and differentiated neural stem cells that maintain pluripotency and genetic stability during large scale production.

Read more at: https://bioinformant.com/cellular-engineering-technologies/

CET specializes in stem cell research, tissue engineering and cancer biology.

We develop media, provide and conduct research on stem cells obtained from human non-embryonic sources, such as adipose tissue, bone marrow, Wharton’s jelly, umbilical cord blood, and placentas. In addition, CET's mission is to be a leading provider of induced pluripotent (IPS) stem cells derived from normal human volunteers and patients with various clinical conditions. Our engineering focus is o